The online version of the original chapter can be found at http://dx.doi.org/10.1007/978-1-4471-5251-4_6
You have full access to this open access chapter, Download chapter PDF
Treatment of Neurological Disorders
Page 305, “Migraine (moderate pain during attack)”:
Tablets, e.g., zolmitriptan (see zolmitriptan tablets); sumatriptan 50 mg or 100 mg, max. 200–300 mg/24 h; and almotriptan 12.5 mg, max. 25 mg/24 h
(Instead of: “Tablets, e.g., zolmitriptan (see zolmitriptan tablets); sumatriptan 50 mg or 100 mg, max. 200–300 mg/24 h; and almotriptan 2.5 mg or 5 mg; for second dose wait 2 h, max. 10 mg/24 h”)
Page 306, “Migraine (preventive treatment)”:
Beta-blockers, e.g., metoprolol 100 mg once or twice daily or 200 mg once daily, and propranolol 20–80 mg once or twice daily
(Instead of: “Beta-blockers, e.g., metoprolol 100–200 mg once or twice daily and propranolol 20–80 mg once or twice daily)
Page 306, “Cluster headache, transitional treatment”:
Ergotamine 1–2 mg, p.o. or as a suppository once or twice daily
(Instead of: “Dihydroergotamine 1–2 mg, p.o. or as a suppository once or twice daily, may be given parenterally as well”)
Page 337, “Treatment of nonmotor symptoms, Hypotension”:
Dihydroergotamine 2.5 mg or 5 mg twice daily
(Instead of: “Ergotamine 5 mg three times daily”)
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Kondziella, D., Waldemar, G. (2014). Erratum Chapter 6 Treatment of Neurological Disorders. In: Neurology at the Bedside. Springer, London. https://doi.org/10.1007/978-1-4471-5251-4_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-5251-4_7
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-5250-7
Online ISBN: 978-1-4471-5251-4
eBook Packages: MedicineMedicine (R0)